Loading...
Loading...
For most startup employees, the moment their company files for an IPO feels like a finish line. Years of below-market salaries, long hours, and option grants are about to pay off. But in the months — sometimes years — before a company goes public, option holders face a decision with enormous financial consequences: whether and when to pursue stock option exercise before startup IPO.
Getting this right requires navigating tax law, company-specific restrictions, personal financial circumstances, and a realistic assessment of your company's IPO timeline. Get it wrong, and you could hand a significant portion of your gains to the IRS unnecessarily — or worse, pay taxes on paper gains that never materialize.
This guide walks through what experienced investors and wealth advisors consider when evaluating stock option exercise before startup IPO — from tax mechanics and holding period strategy to the often-underappreciated risks of concentrated illiquid equity.
When a private company announces plans for a public offering, option holders typically face a lockup period — usually 90 to 180 days after the IPO — during which they cannot sell newly acquired shares. But the decision to exercise options before IPO happens long before the offering is priced. The pre-IPO phase is where the most consequential choices are made, often with incomplete information and genuine time pressure.
Once a company is public, your stock is priced by the market in real time. You can sell, diversify, or hold as you see fit. The structural constraints of private company equity largely fall away. But before that moment, you are working with limited liquidity, significant uncertainty, and tax rules that heavily favor holders who exercised years earlier — sometimes well before the IPO was even announced.
The IRS treats gains on Incentive Stock Options (ISOs) favorably if you meet specific holding period requirements. To qualify for long-term capital gains treatment on ISOs, you generally need to hold the shares for at least two years from the grant date and one year from the exercise date. The IRS outlines these rules directly in Tax Topic 427 — and the implications for employees approaching a pre-IPO inflection point are significant: the holding period clock may need to start well before the offering date to preserve favorable tax treatment.
Not all stock options are created equal. The two most common types — Incentive Stock Options (ISOs) and Non-Qualified Stock Options (NSOs) — are taxed in fundamentally different ways, and this difference drives exercise timing strategy more than almost any other variable.
ISOs offer no ordinary income tax at exercise — though the spread between fair market value and strike price can trigger the Alternative Minimum Tax. If you hold ISO shares long enough to meet IRS holding period requirements, your entire gain is taxed at long-term capital gains rates, which top out at 20% rather than the 37% top marginal rate for ordinary income. There is, however, a $100,000 per-year limit on the value of ISOs that can first become exercisable and retain favorable tax treatment.
NSOs are taxed more straightforwardly but at higher rates. The spread at exercise — fair market value minus your strike price — is taxed as ordinary income the moment you exercise, regardless of whether you sell. Your employer withholds taxes accordingly. There is no AMT exposure, but there is also no special capital gains treatment for the portion taxed at exercise.
For NSO holders, exercising options before going public while the 409A valuation is still relatively low can significantly reduce the ordinary income recognized at exercise. If the stock opens at $40 at IPO but your 409A was $8 when you exercised six months prior, your ordinary income is calculated on the $8 spread — not the $40 spread. That difference can translate directly into a meaningfully lower tax bill.
The Alternative Minimum Tax is perhaps the most dangerous hidden variable for employees considering stock option exercise before startup IPO. Many people encounter AMT for the first time when they exercise a large ISO grant — and the surprise, arriving at tax filing time, can be severe.
When you exercise ISOs, the spread is included in your Alternative Minimum Taxable Income (AMTI), even though you pay no regular income tax at exercise. If your resulting AMT liability exceeds your regular tax liability, you pay the difference. IRS Topic 556 covers the AMT mechanics in detail. For early-stage employees with large grants and low strike prices, this can produce AMT bills in the hundreds of thousands of dollars — on shares you still cannot sell.
In my experience advising clients through pre-IPO situations, the most painful outcomes are rarely failed companies — they are employees who exercised a large ISO block in the year before the IPO, received a massive AMT bill, and then watched the stock price fall sharply after lockup expiration. The tax was real; the gains evaporated. This scenario played out for a meaningful number of tech employees during the 2022-2023 IPO correction, when rising interest rates stalled a generation of anticipated offerings and left exercised shareholders holding illiquid positions far longer than planned.
The standard mitigation strategies include spreading exercises over multiple tax years to keep AMT exposure manageable; exercising only up to your AMT crossover point — the maximum you can exercise in a given year without triggering additional AMT liability above your regular tax; and working with a CPA who specializes in equity compensation. General-purpose tax software does not reliably model ISO AMT exposure. This is a case where specialist advice pays for itself many times over.
Aption's Equity Simulator can give you a starting point for understanding the value landscape of your equity position. For actual AMT modeling, you will want a tax professional who works with option holders on a regular basis.
Assuming you have determined that exercising makes sense in principle, pre-IPO stock option exercise timing comes down to five key variables. Here is the framework experienced advisors use when guiding clients through this decision.
Time your exercise to the 409A valuation cycle. Private companies update their 409A valuations at least annually, and often following significant funding events. Each new funding round generally increases the 409A — which means exercising before the next valuation reset locks in a lower spread. If your company just closed a new round and you expect the next 409A to increase substantially, exercising before that update can meaningfully reduce your taxable event.
Model the holding period math before you act. For ISOs, you need at least one year between exercise date and sale date to qualify for long-term capital gains treatment. If the IPO is 18 months away and the lockup is 6 months, exercising now gives you exactly enough runway. If the IPO is only 6 months out, you would need to hold 6 months past lockup expiration — which may or may not fit your plans. Exercising options before IPO without modeling this timeline first is one of the most common mistakes advisors encounter.
Assess your personal liquidity honestly. Exercise requires real cash: your strike price multiplied by the number of shares, plus potential AMT. At a company approaching IPO, you might have a $0.50 strike price on 100,000 shares — that is $50,000 out of pocket before any tax consideration. Our earlier piece on how to pay for stock options covers the available financing and cashless exercise mechanisms in detail.
Evaluate IPO probability realistically. From a fund management perspective, in any given cohort of late-stage startups, a meaningful proportion either delay their IPO indefinitely, get acquired instead, or never go public at all. Exercising options is a real cash outlay on an illiquid asset. Before committing, ask yourself: if this company does not IPO for another three years, am I comfortable holding these shares? Our guide on whether to buy your equity provides a structured framework for thinking through exactly this question.
Consider the tax calendar. Exercising early in the calendar year maximizes your runway before December 31st — useful if you later need to execute a disqualifying disposition on ISOs, which converts gains to ordinary income but eliminates AMT exposure for that year. Early-year exercises also give you more time to work with your tax advisor before filing season, and allow you to model the full-year picture before committing.
The potential upside of a well-timed exercise is real — but the risks deserve equal space in any honest discussion. Many employees focus on tax optimization and overlook the structural exposures that exercise creates.
Concentration risk is the most underappreciated. When you exercise options before going public, you are converting a financial instrument into actual shares of a single private company — one you likely already depend on for your income. You have increased your exposure to an illiquid asset that may be locked up for another 12 to 18 months minimum. Unlike a public stock, you cannot reduce this position if circumstances change. This is, in effect, a concentrated leveraged bet on a single outcome.
The 2022-2023 IPO drought provides a useful case study. Rising interest rates and public market volatility led many high-growth companies to postpone planned offerings. Employees who had exercised in anticipation of a near-term IPO found themselves holding large illiquid positions — with AMT bills already paid — for far longer than expected. The structural problem for stock and option holders is not new, but that period made the concentration risk unusually visible.
Lockup expiration pressure is another underrated risk. Even after a successful IPO, many companies see significant stock price pressure as lockups expire and employees begin selling. The stock you exercised at a $10 per-share spread may be trading materially lower by the time you can actually sell. Historical analysis of technology IPO cohorts consistently shows that a significant proportion of new public companies trade below their offer price within 12 months — a sobering reminder that the IPO date is not the finish line.
Pre-IPO company risk is also real. Private companies can still fail, be acquired at values below your exercise price, or undergo recapitalizations that significantly dilute common shareholders. In a down-round acquisition or a cramdown scenario, your exercised shares may yield far less than anticipated — or nothing at all. Exercising options is a commitment of real capital; treat it with the same diligence you would apply to any significant investment.
Suppose you have worked through the decision framework, exercised at the right time, and now hold a significant block of shares in a company approaching its IPO. You have navigated the most immediate decision. But you are still facing a classic wealth management challenge: how to manage a highly concentrated, illiquid position.
Even after an IPO and lockup expiration, many employees struggle to sell. There are psychological barriers — "what if it goes higher?" — plus tax considerations and genuine uncertainty about future performance. But the data is consistent: concentrated single-stock positions almost always underperform diversified portfolios over time, and they carry significantly higher downside risk. This is not a theoretical observation. It is among the most robustly documented findings in behavioral finance.
Research in behavioral finance — including work widely cited by Harvard Business Review — has documented how employees consistently overvalue their own employer's stock relative to the broader market. This leads to systematic under-diversification and, over long time horizons, meaningfully worse wealth outcomes. A skilled financial advisor's most important role in these situations is often not tax optimization but helping clients overcome the psychological barriers to reducing concentration.
For employees still in the pre-IPO phase, equity pooling offers a structural path to diversification before your company's liquidity event. Rather than waiting to diversify after an IPO — and then facing the psychological and tax barriers to selling — you can exchange a portion of your concentrated position for exposure to a portfolio of high-growth startups. Introduction to Equity Pooling is the best starting point for understanding how the mechanism works in practice.
Timing your stock option exercise before a startup IPO is one of the most consequential financial decisions a startup employee or founder can make. The difference between a well-timed exercise and a poorly timed one can easily run into six figures — in either direction. The mechanics are learnable; the harder part is honestly assessing your company's IPO probability and your own risk tolerance under pressure.
The core principles hold across most situations: understand whether you hold ISOs or NSOs, model AMT exposure before any significant stock option exercise before startup IPO, time exercises to the 409A cycle, hold long enough to qualify for capital gains treatment where possible, and never underestimate the real risks of concentration and illiquidity. Good pre-IPO stock option exercise timing is not a single decision — it is a process that benefits enormously from specialist tax and financial advice.
If you are approaching a pre-IPO inflection point and want to explore how equity pooling might complement your exercise strategy — providing meaningful diversification before relying on a single company's liquidity event — Aption offers a way to think about your startup equity as part of a broader portfolio, not a single concentrated bet.
The author name used in this article may be a pen name or pseudonym and is used for illustrative and editorial purposes only. This article is for informational purposes only and does not constitute investment, tax, or legal advice. The scenarios and figures presented are hypothetical examples intended for educational purposes only. Past performance of any investment strategy does not guarantee future results. Consult qualified tax, legal, and financial professionals before making any decisions regarding stock options, equity compensation, or financial planning.
Daniel is a former venture capital partner and startup equity strategist with over 15 years of experience advising founders, employees, and institutional investors on equity structures, liquidity events, and portfolio construction.